Revenue: The sum of all revenue fields included for a company's operating activities.
Eton Pharmaceuticals, Inc. (ETON) had Revenue of $17.28M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$17.28M |
$-1.57M |
|
$7.42M |
|
$9.86M |
|
$17.75M |
|
$-0.47M |
|
$-1.03M |
|
$-1.50M |
|
$-1.50M |
|
$-1.57M |
|
$-1.57M |
|
$-1.57M |
|
$-1.57M |
|
$-0.47M |
|
$0.84M |
|
26.89M |
|
26.89M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$49.96M |
|
$0.02M |
|
$34.07M |
|
$84.03M |
|
$25.35M |
|
$29.99M |
|
$34.23M |
|
$59.58M |
|
$24.45M |
|
$-9.43M |
|
$24.45M |
|
26.82M |
|
| Cash Flow Statement Financials | |
$2.09M |
|
$0.00M |
|
$0.39M |
|
$14.94M |
|
$17.42M |
|
$2.48M |
|
$1.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.97 |
|
-- |
|
-- |
|
0.55 |
|
1.23 |
|
57.06% |
|
-2.72% |
|
-2.72% |
|
-- |
|
-8.67% |
|
-9.10% |
|
$2.09M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.54 |
|
1.05 |
|
85.41 |
|
-6.43% |
|
16.67% |
|
-1.87% |
|
-2.89% |
|
$0.91 |
|
$0.08 |
|
$0.08 |
|